Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.5075
+0.0065 (1.30%)
At close: Oct 2, 2026, 4:00 PM EDT
0.5068
-0.0007 (-0.14%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $3.21 million as of October 2, 2026. Its market cap has decreased by -85.24% in one year.
Market Cap
3.21M
Enterprise Value
2.89M
1-Year Change
-85.24%
Ranking
Category
Stock Price
$0.51
ChartMarket Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $3.21M, an increase of 462.28%. That is a compound annual growth rate of 60.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 3.21M | -55.20% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 3.54M |
| Cadrenal Therapeutics | 3.46M |
| Jupiter Neurosciences | 3.30M |
| Revelation Biosciences | 3.19M |
| Aptevo Therapeutics | 3.17M |
| Addex Therapeutics | 3.13M |
| HCW Biologics | 3.10M |
| VivoSim Labs | 3.08M |